POEMs

Focused Extracorporeal Shock Wave Therapy Better Than Placebo to Relieve Pain in Patients with Chronic Plantar Fasciitis

 


FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.


FREE PREVIEW. Purchase online access to read the full version of this article.

Am Fam Physician. 2015 Oct 1;92(7):635.

Clinical Question

Is focused extracorporeal shock wave therapy effective in relieving pain in patients with chronic plantar fasciitis?

Bottom Line

In this study, unlike others, patients with chronic plantar fasciitis treated with extra-corporeal shock wave therapy had greater pain relief than those treated with placebo. (Level of Evidence = 1b)

Synopsis

The outcomes of treating plantar fasciitis with extracorporeal shock wave therapy have been mixed, and the overall improvement has not been believed to be clinically important. These researchers, most of whom had ties to the manufacturer of the ultrasound equipment used in this study, were convinced that their approach would be better, so they randomized 250 patients with at least six months of heel pain to receive three once-weekly treatments of focused extracorporeal shock wave therapy or placebo therapy. The patients had to have already failed at least two pharmacologic treatments and at least two non-pharmacologic treatments, and had to rate their pain as at least a 5 on a 10-point visual analog scale. Patients used the scale to assess three different pain dimensions: taking their first steps in the morning, heel pain while doing daily activities, and heel pain while applying a standardized local pressure. The authors defined treatment success as a 60% reduction in two of these three dimensions. After 12 weeks, they had data on more than 98% of the patients. At the end of the study, the median reduction in pain was 69% in the extracorporeal shock wave therapy group and 34.5% in the placebo group. Slightly more than one-half the patients treated with extracorporeal shock wave therapy had at least a 60% reduction in pain compared with just more than one-third of those treated with placebo (number needed to treat = 6). However, the use of concomitant analgesic medication was similar in each group.

Study design: Randomized controlled trial (double-blinded)

Funding source: Industry

Allocation: Concealed

Setting: Outpatient (specialty)

Reference: Gollwitzer H, Saxena A, DiDomenico LA, et al. Clinically relevant effectiveness of focused extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: a randomized, controlled multicenter study. J Bone Joint Surg Am. 2015; 97( 9): 701– 708.

POEMs (patient-oriented evidence that matters) are provided by EssentialEvidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, please see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.

To subscribe to a free podcast of these and other POEMs that appear in AFP,search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.

This series is coordinated by Sumi Sexton, MD, Associate Medical Editor.

A collection of POEMs published in AFP is available at http://www.aafp.org/afp/poems.



 

Want to use this article elsewhere? Get Permissions


More in AFP


Editor's Collections


Related Content


More in Pubmed

MOST RECENT ISSUE


Dec 1, 2016

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article